Background
Previous studies have identified survival in systemic sclerosis (SSc)-associated pulmonary arterial hypertension (SSc-PAH) to be worse than in idiopathic pulmonary arterial hypertension (IPAH). We investigated differences between these conditions by comparing demographic, haemodynamic and radiological characteristics and outcomes in a large cohort of incident patients.
Methods
651 patients diagnosed with IPAH or SSc-associated pre-capillary pulmonary hypertension were included. Patients with lung disease or ≥2 risk factors for left heart disease were identified leaving a primary analysis set of 375. Sub-group analysis of cardiac magnetic resonance imaging was performed.
Results
Median survival was 7.8 years in IPAH and 3 years in SSc-PAH (pConclusionfrom #AlexandrosSfakianakis via Alexandros G.Sfakianakis on Inoreader http://ift.tt/2kQyS9X
via IFTTT
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου